ImmunityBio, Inc. receives a Strong Buy rating, driven by ANKTIVA's compelling clinical data and major regulatory catalysts ...

The developer of a non-invasive blood-based assay, BCAL hopes to enter the US market by the quicker lab-developed test route.

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, recommending ...

Background Acute inflammatory responses during and after percutaneous coronary intervention (PCI) are associated with subsequent cardiovascular event risk, but limited data exist on acute immune cell ...

In an in-depth interview, Omar Nadeem, MD, explores the promising findings from 20 patients with smoldering myeloma treated with cilta-cel. For decades, patients with smoldering multiple myeloma have ...

High neutrophils and low lymphocytes can mean your body is under severe stress or fighting an infection. A neutrophil-to-lymphocyte ratio (NLR) shows how sick you are and what treatment you may need.

SPOKANE — Many people are already struggling with their seasonal allergy symptoms like itchy eyes and runny nose, but reducing those symptoms could be as easy as taking a shower after you've been ...

What it means: Thrombocytosis is a high platelet count, which can make blood too sticky and raise the risk of clot-related complications like stroke or heart attack. Two main types: Reactive ...

EMERALD-3: Phase III trial of IMFINZI ® (durvalumab) in combination with IMJUDO ® (tremelimumab-actl), with or without lenvatinib, and transarterial chemoembolization (TACE) in patients with ...

DEAR DR. ROACH: Could you please explain the percentages that are given when a study indicates an increase for a particular risk? For example, say a person with mild coronary artery disease is at an ...